News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Optimizing Treatment of Pediatric Atopic Dermatitis

EP. 1: Atopic Dermatitis: Age of Onset and Prevalence

July 24th 2020

EP. 2: Impact of Atopic Dermatitis: Pediatrics Versus Adults

July 24th 2020

EP. 3: Presentation and Severity of Atopic Dermatitis

July 24th 2020

EP. 4: Seeking Care for Atopic Dermatitis

July 24th 2020

EP. 5: Nonpharmacological Approach to Managing Atopic Dermatitis

July 24th 2020

EP. 6: Pediatric AD: State-of-the-Art Treatment

July 24th 2020

EP. 7: Moderate to Severe Disease: Systemic Therapy

July 24th 2020

EP. 8: Monoclonal Antibody Therapy for Pediatrics With AD

July 24th 2020

EP. 9: Monoclonal Antibody Prior Authorization

July 24th 2020

EP. 10: Topical Therapy Approach for Pediatric Atopic Dermatitis

July 24th 2020

EP. 11: First-Line Biologics for Pediatric AD and Psoriasis

July 24th 2020

EP. 12: The Shifting Treatment Paradigm in AD Management

July 24th 2020

EP. 13: Atopic Dermatitis Pathophysiology

July 24th 2020

EP. 14: Pediatric AD: Differential Diagnosis and Tools

July 24th 2020

EP. 15: Monoclonal Antibody FDA Approval for Pediatric Population

July 24th 2020

EP. 16: Monoclonal Antibody Toxicity Profile and Patient Impact

July 24th 2020

EP. 17: Developing Treatments for Pediatric Atopic Dermatitis

July 24th 2020

Trending on HCPLive

Q2 2026 Recap: Dermatology News & Updates

Updated Guidelines and the Current CSU Treatment Landscape

Mechanisms of Action Behind Advanced CSU Therapies

FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants Down to 3 Months with Eczema

JAK Inhibitors, Oral Minoxidil Reshape Hair Loss Care